Startup entity
leadership is the sole category represented across all 1 tracked stories. Todd James is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 5 average consequence score is below the beat benchmark of 6.6 in the same window.
Last mentioned: Mar 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
leadership is the sole category represented across all 1 tracked stories. Todd James is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 5 average consequence score is below the beat benchmark of 6.6 in the same window. Source depth averages 2 original sources per story, versus 2.3 across the same-window beat baseline. Bambusa Therapeutics appears in 1 tracked Startup story from March 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 48 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Bambusa Therapeutics. Shared-story counts are live from our verified record — not editorial picks.
CFO Appointment
Bambusa Therapeutics officially announces Todd James as the new Chief Financial Officer.
Industry Tenure
Todd James builds 20+ years of experience in biopharmaceutical leadership and finance.
Bambusa Therapeutics has appointed Todd James, a biopharmaceutical industry veteran with over 20 years of experience, as its new Chief Financial Officer. The strategic hire signals a focus on strengthening capital markets expertise and investor relations as the company advances its therapeutic pipeline.
Bambusa Therapeutics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
